Dual targeting of EphA2 and FAK in ovarian carcinoma

EphA2 gene silencing has been shown to result in anti-tumor efficacy. Here we considered whether silencing additional targets downstream of EphA2 would further enhance the therapeutic effect. EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposome...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Shahzad, Mian M.K., Lu, Chunhua, Lee, Jeong-Won, Stone, Rebecca L., Mitra, Rahul, Mangala, Lingegowda S., Lu, Yiling, Baggerly, Keith A., Danes, Christopher G., Nick, Alpa M., Halder, Jyotsnabaran, Kim, Hye-Sun, Vivas-Mejia, Pablo, Landen, Charles N., Lopez-Berestein, Gabriel, Coleman, Robert L., Sood, Anil K.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2748749/
https://ncbi.nlm.nih.gov/pubmed/19395869
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares